Patent details

EP3345602 Title: RAPAMYCIN DERIVATIVE FOR TREATING SOLID TUMOURS

Basic Information

Publication number:
EP3345602
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP181557224
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RAPAMYCIN DERIVATIVE FOR TREATING SOLID TUMOURS
French Title of Invention:
DÉRIVÉ DE RAPAMYCINE POUR TRAITER DES TUMEURS SOLIDES
German Title of Invention:
RAPAMYCINDERIVAT ZUR BEHANDLUNG VON FESTEN TUMOREN
SPC Number:

Dates

Filing date:
18/02/2002
Grant date:
06/04/2022
EP Publication Date:
11/07/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/04/2022
EP B1 Publication Date:
06/04/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/02/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/03/2022
 
 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
Wood, Jeanette Marjorie
Address:
Switzerland (CH)

2

Name:
O`Reilly, Terence
Address:
Switzerland (CH)

3

Name:
Lane, Heidi
Address:
Switzerland (CH)

Priority

1

Priority Number:
0104072
Priority Date:
19/02/2001
Priority Country:
United Kingdom (GB)

2

Priority Number:
0124957
Priority Date:
17/10/2001
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 31/436; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202214
Publication date:
06/04/2022
Description:
Grant (B1)
Filing date Document type Number of pages